Mark Harvill

Mark has held leadership positions in global contract research organizations (CROs) for the past 23 years. Throughout Mark’s CRO career, his teams have developed industry-leading client relationships teams to support approvals for numerous blockbuster drugs and medical devices, including three of the world’s top-selling drugs. As the leader of Avomeen, Mark works closely with the senior leadership and project teams to ensure the company delivers exceptional and innovative hard-to-solve product development challenges, while ensuring compliance with rigorous regulatory standards such as cGMP, cGLP and other industry standards.